83324-063-24 : NDC 2025 Code

83324-063-24 : Acetaminophen, Aspirin, Caffeine ( Headache Relief )

Additionally :

You can get information about “83324-063-24” NDC code in 83324-063-24 in HTML format

HTML | 83324-063-24 in TXT (Plain Text) format

TXT | 83324-063-24 in PDF (Portable Document Format)

PDF | 83324-063-24 in XML format

XML formats.

NDC Code : 83324-063-24 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "83324-063-24",
    "PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (83324-063-24)  / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
    "NDC11Code": "83324-0063-24",
    "ProductNDC": "83324-063",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Headache Relief",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen, Aspirin, Caffeine",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250619",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M013",
    "LabelerName": "Chain Drug Marketing Association, Inc.",
    "SubstanceName": "ACETAMINOPHEN; ASPIRIN; CAFFEINE",
    "StrengthNumber": "250; 250; 65",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-06-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250619",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}